Search Blog
October 2018


EVITRADE Announces Acquisition of Hemp Extraction Technology Corp.


By EVITRADE Health Systems Corp.

VANCOUVER, BC / ACCESSWIRE / October 19, 2018 / EVITRADE Health Systems Corp. (CSE: EVA, OTCQB: EVAHF) (the “Company” or “Evitrade”) is pleased to announce that, further to its press release dated October 5, 2018, that it has completed its acquisition of Hemp Extraction Technology Corp. (“HETC”).

Pursuant to the transaction, Evitrade has acquired all of the issued and outstanding common shares of HETC in exchange for an aggregate of 23,333,333 common shares of Evitrade issued at the deemed price of $0.30 per share tothe former holders of HETC common shares. As a result of the completion of the acquisition transaction, HETC has become a wholly-owned subsidiary of Evitrade.

Management of Evitrade believe the acquisition will further enhance Evitrade’s business and commercialization strategies.

For more information, please contact:

C.K. Cheung, CEO & Director
EVITRADE Health Systems Corporation
(formerly Auxellence Health Corporation)
CSE Micro-site: US OTC Markets (OTCQB):


EVITRADE Health Systems Corp. (formerly Auxellence Health Corp.), is a Technology company specializing in the Life Sciences sector looking to deliver effective health solutions with a higher degree of predictability and consistency. The Company is focused in four main areas, Autonomous Medical Care, Molecular Biology, Nutraceutical Solutions and Genetic Selection. Through its Focus on Autonomous Medical Care, the Company offers a physiologically interactive computing platform that integrates medical devices and artificial intelligence applications into a fully automated, personal health management system for hypertension, arrhythmia, diabetes, and obesity.

About HETC

Hemp Extraction Technology Corp. is an Ontario company focussed on the extraction and processing of oils and other extracts from industrial hemp.

Forward Looking Statements; Disclaimers

This news release contains forward-looking statements based on assumptions and judgments of management regarding future events or results. Such statements are subject to a variety of risks and uncertainties which could cause actual events or results to differ materially from those reflected in the forward looking statements. The Company disclaims any intention or obligation to revise or update such statements. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators and on the OTC Markets website which are posted on,, and, respectively. This news release does not constitute an offer to sell or solicitation of an offer to buy any of the securities described herein and accordingly undue reliance should not be put on such. Neither the Canadian Securities Exchange (CSE or CNSX Markets), nor its Regulation Services Provider (as that term is defined in policies of the CSE), or any other regulatory authority accepts responsibility for the adequacy or accuracy of this release. The Company does not undertake to update this news release unless required by applicable law.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have not been registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities law and may not be offered or sold in the “United States”, as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration requirements is available.

SOURCE: EVITRADE Health Systems Corp.

ReleaseID: 525894